In the last 20 years, the emergence of pharmacological treatments for obesity based on gastrointestinal hormones has transformed the therapeutic landscape
The presentation highlighted that: Weight suppression can increase eating disorder risk regardless of BMI Larger degrees of suppression are associated with greater symptom severity Weight suppression is linked to medical instability and poorer recovery outcomes Weight suppression should be understood as a clinical concern rather than a marker of success
People who should not use GLP-1s include: Pregnant people People with a personal or family history of medullary thyroid cancer People with multiple endocrine neoplasia syndrome type 2, a rare condition that affects the endocrine glands People who are hypersensitive to GLP-1 agonist drugs GLP-1 Drugs Are Lifelong Treatments Questions to Ask Your Doctor Am I a candidate for a GLP-1 weight loss drug
Why is that the case
Affordability is access, and helping patients save up to $1,200 per year on Wegovy is a meaningful step toward breaking down that barrier for millions more people, said Zach Reitano, CEO and co-founder of Ro
Proper hydration is essential for maintaining healthy muscle function, and a lack of fluids might exacerbate existing musculoskeletal issues or create new discomforts
